These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5009026)

  • 21. [Studies on the changes in blood coagulation factors through parenteral administration of cobalt(II) compounds in rabbits].
    Wohllebe W; Taube C; Fiedler H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 89(3):315-21. PubMed ID: 4176081
    [No Abstract]   [Full Text] [Related]  

  • 22. The molecular localization of the ability of certain monoclonal immunoglobulins to interfere with fibrin polymerization.
    Wisløff F; Michaelsen TE; Kierulf P; Godal HC
    Thromb Res; 1985 Nov; 40(4):473-82. PubMed ID: 4082120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 24. Iodine-labelled fibrinogen: a review.
    Regoeczi E
    Br J Haematol; 1971 Jun; 20(6):649-63. PubMed ID: 4932961
    [No Abstract]   [Full Text] [Related]  

  • 25. Double myeloma. Production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line.
    Rudders RA; Yakulis V; Heller P
    Am J Med; 1973 Aug; 55(2):215-21. PubMed ID: 4124689
    [No Abstract]   [Full Text] [Related]  

  • 26. [A method of determining the anti-, de- and fibrin-polymerization activity of the blood plasma].
    Pastorova VE; Liapina LA; Kudriashov BA; Tabakina TE
    Lab Delo; 1990; (7):53-7. PubMed ID: 1699071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of a fibrin formation abnormality in a case of multiple myeloma.
    Soria J; Soria C; Samama M; Fine JM; Bousser J
    Scand J Haematol; 1975 Oct; 15(3):207-18. PubMed ID: 812173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition or acceleration of fibrin polymerization by monoclonal immunoglobulins and immunoglobulin fragments.
    Wisløff F; Michaelsen TE; Godal HC
    Thromb Res; 1984 Jul; 35(1):81-90. PubMed ID: 6474410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-immunoglobulin antibodies in immunodeficiencies: their influence on intolerance reactions to gamma-globulin administration.
    Ropars C; Caldera LH; Griscelli C; Homberg JC; Salmon C
    Vox Sang; 1974; 27(4):294-301. PubMed ID: 4137541
    [No Abstract]   [Full Text] [Related]  

  • 30. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer.
    Smith GF; Bang NU
    Biochemistry; 1972 Aug; 11(16):2958-66. PubMed ID: 4261258
    [No Abstract]   [Full Text] [Related]  

  • 31. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
    Marguerie G; Hudry G; Hollard D
    Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
    [No Abstract]   [Full Text] [Related]  

  • 33. Release of a low molecular weight Fc-like fragment on reduction of water-insoluble IgG myeloma proteins.
    Morris GG; Osterland CK; Chaplin H
    Vox Sang; 1974; 27(4):273-86. PubMed ID: 4278247
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of the action of factor XIII on the structure of fibrin in the normal and pathological states.
    Kleimenov AN; Rozenfel'd MA; Piruzyan LA; Titova MI; Shimkevich LL
    Biol Bull Acad Sci USSR; 1978; 5(5):610-4. PubMed ID: 754811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombination experiments with an unusual L-chain related myeloma protein.
    Wetter O; Pfeiffer R
    Acta Haematol; 1973; 49(3):166-75. PubMed ID: 4198451
    [No Abstract]   [Full Text] [Related]  

  • 36. Gamma globulin inhibition of fibrin clot formation.
    Davey FR; Gordon GB; Boral LI; Gottlieb AJ
    Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methods for the determination of pathological hyperfibrinolysis of the blood].
    Perlick E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):171-85. PubMed ID: 4098771
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anomaly of polymerization of fibrin in a case of gamma-A myeloma].
    Krick JA; Ménaché D
    Nouv Rev Fr Hematol; 1966; 6(5):744-8. PubMed ID: 4165868
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fibrin polymerization inhibition by ferritin].
    Bungert HJ
    Blut; 1973 Jul; 27(1):20-5. PubMed ID: 4718811
    [No Abstract]   [Full Text] [Related]  

  • 40. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.